Health-related quality of life, employment and disability in patients with Sjogren's syndrome. - Wikidata - wikimedia - TriplyDB

Health-related quality of life, employment and disability in patients with Sjogren's syndrome.

Health-related quality of life, employment and disability in patients with Sjogren's syndrome.

http://www.wikidata.org/entity/Q49160025

about

Making the diagnosis of Sjögren's syndrome in patients with dry eye A systematic review of non-pharmacological interventions for primary Sjögren's syndrome Interleukin-1 inhibition and fatigue in primary Sjögren's syndrome--a double blind, randomised clinical trial Sjögren's syndrome is associated with negatively variable impacts on domains of health-related quality of life: evidence from Short Form 36 questionnaire and a meta-analysis Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment Text-mining applied to autoimmune disease research: the Sjögren's syndrome knowledge base.An investigation into the prevalence of sleep disturbances in primary Sjögren's syndrome: a systematic review of the literature Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes United Kingdom Primary Sjogren's Syndrome Registry--a united effort to tackle an orphan rheumatic disease.Role of structure and glycosylation of adsorbed protein films in biolubrication.Chinese Herbal Medicine in Treating Primary Sjögren's Syndrome: A Systematic Review of Randomized Trials.The lived experience of Sjögren's Syndrome.Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial.Vision-related quality of life and psychological status in Chinese women with Sjogren's syndrome dry eye: a case-control study.It's more than dryness and fatigue: The patient perspective on health-related quality of life in Primary Sjögren's Syndrome - A qualitative study Reduced Mucin-7 (Muc7) Sialylation and Altered Saliva Rheology in Sjögren's Syndrome Associated Oral Dryness.Systems analysis of primary Sjögren's syndrome pathogenesis in salivary glands identifies shared pathways in human and a mouse model.Cognition, depression, fatigue, and quality of life in primary Sjögren's syndrome: correlations.Interleukin-1 as a mediator of fatigue in disease: a narrative review.Primary Sjogren's syndrome: too dry and too tired.Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study.Biological therapies in primary Sjögren's syndrome.Treatment of primary Sjögren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point?Sjögren's syndrome in older patients: aetiology, diagnosis and management.Relationship of EQ-5D quality of life with the presence of co-morbidity and extra-articular features in patients with rheumatoid arthritis.The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms.Effectiveness of Traditional Chinese Medicine Compound JieDuTongLuoShengJin Granules Treatment in Primary Sjögren's Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.Safety of treatments for primary Sjögren's syndrome.Depression in primary Sjögren's syndrome: a systematic review and meta-analysis.Modeling quality of life in patients with rheumatic diseases: the role of pain catastrophizing, fear-avoidance beliefs, physical disability, and depression.The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.Adherence to online monitoring of patient-reported outcomes by patients with chronic inflammatory diseases: a feasibility study.Primary Sjögren's syndrome in Moroccan patients: characteristics, fatigue and quality of life.A possible genetic association with chronic fatigue in primary Sjögren's syndrome: a candidate gene study.Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment.Dental Implants in Patients with Sjögren's Syndrome.Patient burden of Sjögren's: a comprehensive literature review revealing the range and heterogeneity of measures used in assessments of severity.Health-related utility values of patients with primary Sjögren's syndrome and its predictors.Impaired functional status in primary Sjögren's syndrome.Recombinant supercharged polypeptides restore and improve biolubrication.

P2860

Q26772031-6BEE5247-D5E1-4977-BCDE-CF8E2373B52B Q26830909-636EFD08-E6CE-403C-82F1-D99CE5444A1F Q28478765-C26D35E1-D43F-4A62-9550-1EB4274355F6 Q30234353-B0D199D6-5C1E-482B-8570-39ECB9CCAAEE Q30234992-59B271DE-7958-4F40-80EA-BE1637497636 Q31070967-F78A581C-7BB1-4937-81EF-2EA917847256 Q33620583-3217CD6E-FB69-4067-A86B-2EB209E6B763 Q34083843-CD3633BC-A7BA-444F-8708-1D43A4AE7083 Q34130258-6117E3CF-4E17-4EB4-9786-66481A4F54E0 Q34390912-6FE8C080-016C-48AD-998C-0DB0C1EE9844 Q34411922-5DFFB71E-4CC9-4A75-9516-DC3B32E9BF0A Q35910434-856BE240-2A52-4403-9D82-2E7C53282996 Q36070691-63F10B27-ACE2-407C-B2C0-E7CBE49649B2 Q36220908-B0E36C78-235F-42B9-B3D6-72326066FF9D Q36275817-5C7F0854-00D9-499D-AB29-B1931B6DB0A1 Q36745083-9F36B4E6-55BD-4897-8F31-F3737410F19B Q36907609-EB676DCC-DAE5-4A3C-8736-F70BB93CFE14 Q37514488-F5E087B8-BD34-4146-AF0F-30802D925D7C Q37597282-6F73D8F7-5645-43E2-8883-633175836296 Q37690497-3A517A3C-3394-49C6-90BB-D62DE9AC6B0E Q37691074-08A5F150-2992-4C2C-A44D-68F923D74580 Q37860347-CC3EE04C-18A9-439E-8478-0310792F6B9F Q37912214-DF85D9E7-3803-4E2D-9057-D0EA32E56010 Q38076070-3467FD03-77CA-407F-92CF-FB9164882FEA Q38169961-0869C87B-3DE1-4A58-B446-68FCCCE1F7FC Q38186111-96BF60E3-71E1-4E59-8FB4-A528C7FE7610 Q38645543-DE119D9F-811A-43C4-B60C-D4EB2E50370C Q38711144-1954BD75-F10D-40A8-939F-99FC9EF66339 Q38722820-18DF9178-4F10-4A7C-BDE9-4FE3EB9CD57F Q38908843-B05D756A-658D-4B12-A4D9-4DCB6C61FC73 Q38913854-6F85EB9F-BCDA-4651-93CA-0B38EDFE3669 Q39007658-96F1CF00-6D16-454F-838D-FB6A154EE29C Q39091639-473B7A58-936D-477A-9E4C-C3D3D470CD0B Q39356677-7423AD86-CB75-4D00-BC0A-0A759D3A80A4 Q40117123-61B3B2A1-5083-4596-A85F-7845BFDB46C4 Q40509259-51EBB90C-B164-4E80-8EDB-BB5513F3AA0A Q41687111-CFA4E928-E509-43A6-8588-18485A0D4FAA Q43439981-5EA7C7CD-A609-4EE7-B28D-1351080B6632 Q44473952-66D91B0D-16C0-4052-A15D-CB2DD2FC7E26 Q46192021-B4E18DFA-0AA6-4547-B4B9-BB429F4B2D7D

P2860

Health-related quality of life, employment and disability in patients with Sjogren's syndrome.

http://www.wikidata.org/entity/Q49160025

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Health-related quality of life ...... ients with Sjogren's syndrome.

@en

Health-related quality of life ...... ients with Sjogren's syndrome.

@nl

type

label

Health-related quality of life ...... ients with Sjogren's syndrome.

@en

Health-related quality of life ...... ients with Sjogren's syndrome.

@nl

prefLabel

Health-related quality of life ...... ients with Sjogren's syndrome.

@en

Health-related quality of life ...... ients with Sjogren's syndrome.

@nl

P1433

Q49160025-BC3033FE-B661-4EFD-9BCE-036D6D701FA8

P1476

Q49160025-C0DCBC08-106B-4E0E-A96E-A05C9AC2163F

P2093

Q49160025-0415895B-1CF4-4736-817A-F9A160D4CD58

Q49160025-1EC9E2A6-45ED-4A7E-A878-330BD6F85DF2

Q49160025-7517554B-EAC6-4CB6-8EA0-D24EDB6C66A3

Q49160025-7E30D0E7-E685-4C59-9CFB-F6E7FAE0FA9B

Q49160025-ADEFCE84-D828-4B6D-8BEA-7BD664C675B3

Q49160025-C664BA51-F7B2-48B6-98DF-E790C6EC94CB

P2860

Q49160025-0D086699-7768-43BA-A484-57A4342610EB

Q49160025-17AF33CB-64C8-456E-8306-8412BDC0F8C2

Q49160025-211A807C-54B1-4EFC-B1EA-9D9714ED2A3B

Q49160025-47C2BD12-86FD-4AA8-BBD6-FCF037B97F71

Q49160025-4BAD93FC-0AEE-4311-A080-BC341F06A559

Q49160025-4DC8D313-C357-49DA-ADEC-8A1E99A30B85

Q49160025-60349066-A0D9-47BB-ACA3-FE8CB1CA9B49

Q49160025-63FF9306-33D6-440B-AABF-BA9874121F30

Q49160025-68A4D45B-29C3-4EF0-9436-95F2F7EE1044

Q49160025-8878FF9C-124B-4915-BD12-0CAF52C71971

P304

Q49160025-CFAB27A9-DF5F-43F0-A350-C4D748B369D7

P31

Q49160025-4B17FA9C-9D1C-408A-9760-057F69875559

P356

Q49160025-0A5FE0F5-0631-4759-B3D7-8CAD1D09A813

P433

Q49160025-656D7027-092A-420E-923F-DBCD9B70AF47

P478

Q49160025-443F5457-E553-45F1-9A84-0B94885DABDF

P50

Q49160025-5EAD57A0-EFE4-468C-964F-2052901E2FF1

P577

Q49160025-2FF9FEAE-60CC-4934-880A-50E8E4F1473D

P5875

Q49160025-5D46B35A-0A45-43AA-99A6-FDECBF33C7C9

P698

Q49160025-E556BA27-F680-493E-917F-59B665B59E82

P921

Q49160025-1AFD3D72-37A6-4A7B-B1FA-CAB3A5277F73

Q49160025-4D39BBBC-55F6-481E-8B09-E2573A2BCD88

P356

P1433

P1476

Health-related quality of life ...... ients with Sjogren's syndrome.

@en

P2093

Arjan Vissink

http://www.w3.org/2001/XMLSchema#string

Fred K L Spijkervet

http://www.w3.org/2001/XMLSchema#string

Hendrika Bootsma

http://www.w3.org/2001/XMLSchema#string

James J R Huddleston Slater

http://www.w3.org/2001/XMLSchema#string

Jiska M Meijer

http://www.w3.org/2001/XMLSchema#string

Petra M Meiners

http://www.w3.org/2001/XMLSchema#string

P2860

The future of biologic agents in the treatment of Sjögren's syndrome

Health-related quality of life in primary Sjögren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36.

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients.

Primary Sjögren syndrome: hematologic patterns of disease expression.

Prevalence, severity, and predictors of fatigue in subjects with primary Sjögren's syndrome.

Fatigue in primary Sjögren's syndrome

Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age

Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjogren's syndrome and associated MALT lymphoma.

Immunopathogenesis of primary Sjögren's syndrome: implications for disease management and therapy.

P304

1077-1082

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/RHEUMATOLOGY/KEP141

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

Cees G M Kallenberg

P577

2009-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26317772

http://www.w3.org/2001/XMLSchema#string

P698

19553376

http://www.w3.org/2001/XMLSchema#string

P921

quality of life